Biomimetic proteolipid nanovesicles for delivery of nucleic acids
AssigneeThe Methodist Hospital
InventorsManuela SUSHNITHA, Francesca TARABALLI, Assaf Yosef ZINGER, Chiara MANCINO
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Methodist Hospital
InventorsManuela SUSHNITHA, Francesca TARABALLI, Assaf Yosef ZINGER, Chiara MANCINO
Estimating the term…
Disclosed herein is a biomimetic proteolipid nanovesicle, comprising: an ionizable or cationic lipid; a phosphocholine-based phospholipid; a cholesterol; a leukocyte membrane protein; and an siRNA encapsulated by the biomimetic proteolipid nanovesicle; wherein the biomimetic proteolipid nanovesicle has a lipid-to-protein ratio of from about 1:65 to about 1:85 by weight. Further disclosed herein is a biomimetic proteolipid nanovesicle, comprising: an ionizable or cationic lipid; a phosphocholine-based phospholipid; a cholesterol; a leukocyte membrane protein; and an mRNA encapsulated by the biomimetic proteolipid nanovesicle; wherein the biomimetic proteolipid nanovesicle has a lipid-to-protein ratio of from about 1:80 to about 1:100 by weight.
A biomimetic proteolipid nanovesicle, comprising:
A biomimetic proteolipid nanovesicle, comprising:
Dependencies are inferred from the claim text.